MYDRILATE

This brand name is authorized in Ireland, United Kingdom

Active ingredients

The drug MYDRILATE contains one active pharmaceutical ingredient (API):

1 Cyclopentolate UNII 736I6971TE - CYCLOPENTOLATE HYDROCHLORIDE

Cyclopentolate is an antimuscarinic agent used topically in the eye as a mydriatic and cycloplegic. The effects are similar to those of atropine, but with a more rapid onset and a shorter duration of action. Read about Cyclopentolate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYDRILATE 1.0% Eye drops	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FA04	Cyclopentolate	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 14860, 14861
Country: IE	Health Products Regulatory Authority	Identifier(s): 35041, 35068